The proportion of people with a rheumatic disease getting severe COVID has diminished since early in the pandemic INTRODUCTION COVID-19 (often referred to as COVID) is the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization in March 2020. The infections caused by the initial […]
Category: COVID-19
COVID boosters in AIIRD
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre study. INTRODUCTION COVID-19 is the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization in March 2020. Vaccination against SARS-CoV-2 […]
Flare likely after vaccination, but can be prevented with colchicine
COVID-19 vaccination associated with increased likelihood of gout flare INTRODUCTIONM Gout is a very common condition, affecting up to 2–4% of adults in developed countries. The symptoms tend to flare every so often, developing over a few hours and causing severe pain in the joints. It is caused by deposits of crystals of a substance […]
Fully vaccinated people with systemic rheumatic diseases have less severe COVID outcomes
Breakthrough COVID-19 had lower hospitalisation and mortality in vaccinated patients INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to change their behaviours to try to limit […]
Updated: COVID-19 vaccination recommendations in RMDs
This is the lay version of the EULAR recommendations for COVID-19 vaccination in people with rheumatic and musculoskeletal diseases. The original publication can be downloaded from the EULAR website: www.eular.org. Landewé RBM, Kroon FPB, Alunno A, et al. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context […]
Update: Using rheumatology drugs for COVID-19
This is the lay version of the EULAR points to consider on the use of medicines traditionally used in rheumatology to treat the inflammation seen in people with severe COVID-19. The original publication can be downloaded from the EULAR website: www.eular.org. Alunno A, et al. 2021 update of the EULAR points to consider on the […]
Medication use for rheumatoid arthritis affects COVID-19 outcomes
People with rheumatoid arthritis treated with rituximab or JAKi have worse COVID-19 severity than those on TNFi INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to […]
For COVID-19, general health status matters more than inflammatory arthritis
For people with inflammatory arthritis, overall COVID-19 risks are low and similar to those in the general population. INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people […]
Increased COVID-19 risk in autoimmune disease, but not more severe
People with autoimmune disease have an increased risk of getting infected with COVID-19, especially if they use steroid medicines. However, the risk of severe outcomes of COVID-19 such as hospitalisation or death is not increased. INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It […]
COVID-19-related death in rheumatic diseases
This is the lay version of a paper published on behalf of the COVID-19 Global Rheumatology Alliance Consortium. It examines COVID-19-related death in people with rheumatic diseases. The original publication can be downloaded from the EULAR website: www.eular.org. Strangfeld A, et al. Factors Associated with COVID-19-related Death in People with Rheumatic Diseases: Results from the […]
